You just read:

Cerebral Therapeutics Raises Series A Extension Financing to Advance Clinical-Stage Drug Device Combination Therapy to Phase 3 Readiness for Adult Refractory Epilepsy

News provided by

Cerebral Therapeutics

Mar 08, 2019, 07:05 ET